Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jeremy Green, Redmile Group Drop Cyclacel Pharmaceuticals Like It’s Hot

Jeremy Green, Redmile Group: In a passive 13G filing with the SEC just now, the San Francisco-based Redmile Group, managed by Jeremy Green, has closed out its position in Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC). Cyclacel is a bio-therapeutics firm focusing on antibody-based treatments. Shares are down over 5% on the day.

Disclosure: none

Loading...